2. GPCR/G Protein Immunology/Inflammation Neuronal Signaling Membrane Transporter/Ion Channel
  3. CCR Calcium Channel Arrestin P-glycoprotein
  4. IDOR-1117-2520

IDOR-1117-2520 is an orally active, potent, selective and reversible CCR6 antagonist. IDOR-1117-2520 antagonizes the CCL20-mediated calcium flow (IC50 = 63 nM) and inhibits β-arrestin recruitment to human CCR6 (IC50 = 30 nM) in cells expressing recombinant human CCR6. IDOR-1117-2520 is found to be a substrate of P-gp/MDR1. IDOR-1117-2520 can be used in the research of autoimmune diseases and skin inflammation.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

IDOR-1117-2520

IDOR-1117-2520 화학구조

CAS No. : 2737274-49-4

사이즈 가격 재고 수량
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
 해외재고보유
Solution
10 mM * 1 mL in DMSO 해외재고보유
Solid
5 mg 해외재고보유
10 mg 해외재고보유
25 mg 해외재고보유
50 mg   견적 받기  
100 mg   견적 받기  

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

고객리뷰

Based on 1 Customer Validation

Other Forms of IDOR-1117-2520:

IDOR-1117-2520 Related Antibodies

Top Publications Citing Use of Products

View All CCR Isoform Specific Products:

View All Isoforms
CCR1 CCR2 CCR3 CCR4 CCR5 CCR6 CCR7 CCR8 CCR9

View All Calcium Channel Isoform Specific Products:

View All Isoforms
N-type calcium channel L-type calcium channel P/Q-type calcium channel T-type calcium channel Calcium Channel

View All Arrestin Isoform Specific Products:

View All Isoforms
Arrestin-2/β-Arrestin 1 Arrestin-3/β-Arrestin 2

  • Biological Activity

  • 순도&문서

  • References

  • 고객리뷰

제품 설명

IDOR-1117-2520 is an orally active, potent, selective and reversible CCR6 antagonist. IDOR-1117-2520 antagonizes the CCL20-mediated calcium flow (IC50 = 63 nM) and inhibits β-arrestin recruitment to human CCR6 (IC50 = 30 nM) in cells expressing recombinant human CCR6. IDOR-1117-2520 is found to be a substrate of P-gp/MDR1. IDOR-1117-2520 can be used in the research of autoimmune diseases and skin inflammation[1][2].

IC50 & Target[1][2]

CCR6

 

In Vitro

IDOR-1117-2520 (100 μM) has no effect at in HepaRG cells[1].
IDOR-1117-2520 antagonizes CCL20-mediated calcium influx in cells expressing recombinant human CCR6 (IC50 = 63 nM) and inhibits CCL20-induced β-arrestin recruitment to human CCR6 (IC50 = 30 nM)[1].
IDOR-1117-2520 (50 nM) inhibits the migration of B cells and T cells towards CCL20, with inhibition rates of 40% and 50% of the maximum migration, respectively[1].
IDOR-1117-2520 is found to be a substrate of P-gp/MDR1 but not of BCRP and also not of the uptake transporters OATP1B1 and OATP1B3[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

IDOR-1117-2520 Related Antibodies
In Vivo

IDOR-1117-2520 (10-100 mg/kg for rats, 3-10 mg/kg for dogs; p.o.) is rapidly absorbed in rats and dogs, with peak plasma concentrations of IDOR-1117-2520 reached within 0.3-0.8 h[1].
IDOR-1117-2520 (0.02-1  mg/mL; p.o. via drinking water; 8  days) reduces CCR6+ cell migration and ear thickness in the Aldara® mouse model of skin inflammation[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Aldara® mouse model of skin inflammation[2]
Dosage: 0.02, 0.1, 0.3, 0.5 and 1  mg/mL
Administration: p.o. via drinking water; 8  days
Result: Reduced ear thickness in animals treated over a period of 8 days in a dose-dependent manner with a maximal observed efficacy achieved with 0.5  mg/mL.
Showed a significant reduction of infiltrating CCR6+ T cells at the end of the study (day 8).
Animal Model: Aldara® mouse model of skin inflammation[2]
Dosage: 50  mg/kg
Administration: Gavage; twice per day; started on day 0, 3 or 5 post Aldara® treatment until day 7.
Result: Significantly reduced the degree of swelling, and this reduction continued until the end of the study on day 8.
Reduced the amount of CD3+ CCR6+ cells at day 8.
분자량

436.55

화학식

C25H32N4O3
CAS No.
Appearance

Solid

Color

White to off-white

SMILES

CC(C1=CC=C([C@@](C2=CC(C3=NOC(C(C)(O)C)=N3)=CN=C2)(O)C4(CN(C4)C)C)C=C1)C
선적

Room temperature in continental US; may vary elsewhere.
보관
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
용액&용해도
In Vitro: 

DMSO : 25 mg/mL (57.27 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.2907 mL 11.4534 mL 22.9069 mL
5 mM 0.4581 mL 2.2907 mL 4.5814 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • 몰농도 계산기

  • 농도 희석 계산기

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
순도&문서

Purity: 99.94%

SDS (251 KB)

COA (253 KB) HNMR (397 KB) RP-HPLC (233 KB) LCMS (94 KB)

Handling Instructions (2659 KB)
References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 2.2907 mL 11.4534 mL 22.9069 mL 57.2672 mL
5 mM 0.4581 mL 2.2907 mL 4.5814 mL 11.4534 mL
10 mM 0.2291 mL 1.1453 mL 2.2907 mL 5.7267 mL
15 mM 0.1527 mL 0.7636 mL 1.5271 mL 3.8178 mL
20 mM 0.1145 mL 0.5727 mL 1.1453 mL 2.8634 mL
25 mM 0.0916 mL 0.4581 mL 0.9163 mL 2.2907 mL
30 mM 0.0764 mL 0.3818 mL 0.7636 mL 1.9089 mL
40 mM 0.0573 mL 0.2863 mL 0.5727 mL 1.4317 mL
50 mM 0.0458 mL 0.2291 mL 0.4581 mL 1.1453 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

IDOR-1117-2520 Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

IDOR-1117-25202737274-49-4CCRCalcium ChannelArrestinP-glycoproteinCC chemokine receptorCa2+ channelsCa channelsP-gpPgpMultidrug resistance protein 1MDR1ATP-binding cassette sub-family B member 1ABCB1Cluster of differentiation 243CD243lung inflammationautoimmune diseaseskin inflammationmiceInhibitorinhibitorinhibit

최근 본 상품:

온라인 문의

Your information is safe with us. * Required Fields.

상품명

  

Requested Quantity *

고객명 *

 

호칭

메일주소 *

 

전화번호 *

Department

 

회사명 *

City

도

Country or Region *

      

비고

대량구매 문의

Inquiry Information

상품명:
IDOR-1117-2520
Cat. No.:
HY-162495
수량:
MCE Japan Authorized Agent:

고객리뷰

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

상품명

  

Lot #

고객명 *

 

메일주소 *

전화번호

 

Department *

회사명 *

 

Country or Region *

비고

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB) Italian - IT (251 KB) Korean - KR (251 KB) Portuguese - PT (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.